BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7881035)

  • 21. Serotonin depletion exacerbates changes in striatal gene expression following quinolinic acid injection.
    Cummings TJ; Walker PD
    Brain Res; 1996 Dec; 743(1-2):240-8. PubMed ID: 9017251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease.
    Senatorov VV; Ren M; Kanai H; Wei H; Chuang DM
    Mol Psychiatry; 2004 Apr; 9(4):371-85. PubMed ID: 14702090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrolytic lesion of globus pallidus ameliorates the behavioral and neurodegenerative effects of quinolinic acid lesion of the striatum: a potential novel treatment in a rat model of Huntington's disease.
    Joel D; Ayalon L; Tarrasch R; Veenman L; Feldon J; Weiner I
    Brain Res; 1998 Mar; 787(1):143-8. PubMed ID: 9518584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complex motor disturbances in a sequential double lesion rat model of striatonigral degeneration (multiple system atrophy).
    Scherfler C; Puschban Z; Ghorayeb I; Goebel GP; Tison F; Jellinger K; Poewe W; Wenning GK
    Neuroscience; 2000; 99(1):43-54. PubMed ID: 10924951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
    Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
    Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iron porphyrinate Fe(TPPS) reduces brain cell damage in rats intrastriatally lesioned by quinolinate.
    González-Cortés C; Salinas-Lara C; Gómez-López MA; Tena-Suck ML; Pérez-De La Cruz V; Rembao-Bojórquez D; Pedraza-Chaverrí J; Gómez-Ruiz C; Galván-Arzate S; Ali SF; Santamaría A
    Neurotoxicol Teratol; 2008; 30(6):510-9. PubMed ID: 18579343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. γ-Aminobutyric acid type B receptor changes in the rat striatum and substantia nigra following intrastriatal quinolinic acid lesions.
    Rekik L; Daguin-Nerrière V; Petit JY; Brachet P
    J Neurosci Res; 2011 Apr; 89(4):524-35. PubMed ID: 21290407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Excitotoxic and metabolic damage to the rodent striatum: role of the P75 neurotrophin receptor and glial progenitors.
    Hanbury R; Charles V; Chen EY; Leventhal L; Rosenstein JM; Mufson EJ; Kordower JH
    J Comp Neurol; 2002 Mar; 444(4):291-305. PubMed ID: 11891644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human neural stem cell transplants improve motor function in a rat model of Huntington's disease.
    McBride JL; Behrstock SP; Chen EY; Jakel RJ; Siegel I; Svendsen CN; Kordower JH
    J Comp Neurol; 2004 Jul; 475(2):211-9. PubMed ID: 15211462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington's disease.
    Alexi T; Hughes PE; van Roon-Mom WM; Faull RL; Williams CE; Clark RG; Gluckman PD
    Exp Neurol; 1999 Sep; 159(1):84-97. PubMed ID: 10486177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quinolinic acid-induced increases in calbindin D28k immunoreactivity in rat striatal neurons in vivo and in vitro mimic the pattern seen in Huntington's disease.
    Huang Q; Zhou D; Sapp E; Aizawa H; Ge P; Bird ED; Vonsattel JP; DiFiglia M
    Neuroscience; 1995 Mar; 65(2):397-407. PubMed ID: 7777157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sertraline and venlafaxine improves motor performance and neurobehavioral deficit in quinolinic acid induced Huntington's like symptoms in rats: Possible neurotransmitters modulation.
    Gill JS; Jamwal S; Kumar P; Deshmukh R
    Pharmacol Rep; 2017 Apr; 69(2):306-313. PubMed ID: 28178592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quinolinic acid lesion of the striatum induces impairment in spatial learning and motor performance in rats.
    Block F; Kunkel M; Schwarz M
    Neurosci Lett; 1993 Jan; 149(2):126-8. PubMed ID: 8474683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Environmental enrichment brings a beneficial effect on beam walking and enhances the migration of doublecortin-positive cells following striatal lesions in rats.
    Urakawa S; Hida H; Masuda T; Misumi S; Kim TS; Nishino H
    Neuroscience; 2007 Feb; 144(3):920-33. PubMed ID: 17161913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenosine A2A receptor blockade before striatal excitotoxic lesions prevents long term behavioural disturbances in the quinolinic rat model of Huntington's disease.
    Scattoni ML; Valanzano A; Pezzola A; March ZD; Fusco FR; Popoli P; Calamandrei G
    Behav Brain Res; 2007 Jan; 176(2):216-21. PubMed ID: 17123640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enkephalinergic striatal projection neurons become less affected by quinolinic acid than substance P-containing striatal projection neurons as rats age.
    Sun Z; Chen Q; Reiner A
    Exp Neurol; 2003 Dec; 184(2):1034-42. PubMed ID: 14769398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nigrostriatal pathway modulates striatum vulnerability to quinolinic acid.
    Buisson A; Pateau V; Plotkine M; Boulu RG
    Neurosci Lett; 1991 Oct; 131(2):257-9. PubMed ID: 1837072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease.
    Araujo DM; Cherry SR; Tatsukawa KJ; Toyokuni T; Kornblum HI
    Exp Neurol; 2000 Dec; 166(2):287-97. PubMed ID: 11085894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quinolinic acid lesion induces changes in rat striatal glutathione metabolism.
    Cruz-Aguado R; Francis-Turner L; Díaz CM; Antúnez I
    Neurochem Int; 2000 Jul; 37(1):53-60. PubMed ID: 10781845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioral and anatomical effects of quinolinic acid in the striatum of the hemiparkinsonian rat.
    Olds ME; Jacques DB; Kopyov O
    Synapse; 2005 Jan; 55(1):26-36. PubMed ID: 15499610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.